<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://imedic.health/en/health/news/childhood-pneumonia-diagnosis-physical-exam-limitations</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-30</news:publication_date>
      <news:title>Childhood Pneumonia Diagnosis: Why a Physical Exam May Not Be Enough</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/olympic-paralympic-athletes-oral-health-risks-performance</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-30</news:publication_date>
      <news:title>Olympic and Paralympic Athletes Face Overlooked Oral Health Risks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/china-30-day-ind-pathway-global-clinical-trials</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-30</news:publication_date>
      <news:title>China’s 30-Day IND Review Pathway Could Reshape Global Clinical Trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/tally-health-scientist-ardd-longevity-drug-development</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-30</news:publication_date>
      <news:title>Tally Health Scientist Joins ARDD Meeting as Longevity Drug Research Faces Clinical Test</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/geroscience-drug-trials-delay-multiple-age-related-diseases</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-30</news:publication_date>
      <news:title>Geroscience Drug Trials: Can One Treatment Delay Multiple Age-Related Diseases?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/ketogenic-diet-metabolic-health-benefits-risks-safety</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-30</news:publication_date>
      <news:title>Ketogenic Diet and Metabolic Health: Benefits, Risks and Safety</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/longevity-drug-research-ardd-clinical-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-31</news:publication_date>
      <news:title>Longevity Drug Research at ARDD: What Counts as Clinical Evidence?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/china-faster-ind-review-trial-readiness-patient-safety</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-31</news:publication_date>
      <news:title>Faster IND Reviews Put Clinical Trial Readiness and Patient Safety in Focus</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/fda-national-priority-voucher-faster-drug-reviews</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-31</news:publication_date>
      <news:title>FDA National Priority Vouchers Could Accelerate High-Impact Drug Reviews</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://imedic.health/en/health/news/cspc-rsv-vaccine-fda-us-clinical-trials</loc>
    <news:news>
      <news:publication>
        <news:name>iMedic</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01</news:publication_date>
      <news:title>CSPC RSV Vaccine Candidate Cleared to Begin U.S. Clinical Trials</news:title>
    </news:news>
  </url>
</urlset>
